Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W De Groot

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipientsW Den Otter, J W De Groot, H F Dullens
International Journal of Tissue Reactions|January 1, 1982
Peritoneal cell populations during tumour injectionE De Heer, J W De Groot, W Den Otter, et al.
Immunobiology|June 1, 1989
Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF)J W De Groot, R A De Weger, R J Vandebriel, et al.
Immunobiology|April 1, 1986
Lymphocyte-induced macrophage cytotoxicity. III. Induction of specific macrophage cytotoxicity is independent of lipopolysaccharideR A de Weger, H van Loveren, J W de Groot, et al.
Immunobiology|March 1, 1984
A macrophage factor enhancing the systemic anti-tumour effect of T lymphocytesH van Loveren, J W de Groot, J W Koten, et al.
Journal of Leukocyte Biology|October 1, 1986
Tumor growth stimulatory macrophages induced by a subclinical bacterial infection in vivoJ W De Groot, P I Compier-Spies, B Wilbrink, et al.
International Journal of Cancer|March 1, 1994
Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigensJ J Bergers, W Den Otter, H F Dullens, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1993
Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in miceJ J Bergers, W Den Otter, H F Dullens, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cellsJ J Bergers, W Den Otter, J W De Groot, et al.
International Journal of Cancer|May 3, 1996
Optimal regimes for local IL-2 tumour therapyW Den Otter, J W De Groot, M R Bernsen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipientsW Den Otter, J W De Groot, H F Dullens
International Journal of Tissue Reactions|January 1, 1982
Peritoneal cell populations during tumour injectionE De Heer, J W De Groot, W Den Otter, et al.
Immunobiology|June 1, 1989
Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF)J W De Groot, R A De Weger, R J Vandebriel, et al.
Immunobiology|April 1, 1986
Lymphocyte-induced macrophage cytotoxicity. III. Induction of specific macrophage cytotoxicity is independent of lipopolysaccharideR A de Weger, H van Loveren, J W de Groot, et al.
Immunobiology|March 1, 1984
A macrophage factor enhancing the systemic anti-tumour effect of T lymphocytesH van Loveren, J W de Groot, J W Koten, et al.
Journal of Leukocyte Biology|October 1, 1986
Tumor growth stimulatory macrophages induced by a subclinical bacterial infection in vivoJ W De Groot, P I Compier-Spies, B Wilbrink, et al.
International Journal of Cancer|March 1, 1994
Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigensJ J Bergers, W Den Otter, H F Dullens, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1993
Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in miceJ J Bergers, W Den Otter, H F Dullens, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cellsJ J Bergers, W Den Otter, J W De Groot, et al.
International Journal of Cancer|May 3, 1996
Optimal regimes for local IL-2 tumour therapyW Den Otter, J W De Groot, M R Bernsen, et al.
Pageof 2